FR2450108A1 - Agent antitumoral contenant la souche lactobacillus casei yit 9018 - Google Patents

Agent antitumoral contenant la souche lactobacillus casei yit 9018

Info

Publication number
FR2450108A1
FR2450108A1 FR8004213A FR8004213A FR2450108A1 FR 2450108 A1 FR2450108 A1 FR 2450108A1 FR 8004213 A FR8004213 A FR 8004213A FR 8004213 A FR8004213 A FR 8004213A FR 2450108 A1 FR2450108 A1 FR 2450108A1
Authority
FR
France
Prior art keywords
strain
antitumor agent
lactobacillus casei
agent containing
casei yit
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR8004213A
Other languages
English (en)
Other versions
FR2450108B1 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Yakult Honsha Co Ltd
Original Assignee
Yakult Honsha Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yakult Honsha Co Ltd filed Critical Yakult Honsha Co Ltd
Publication of FR2450108A1 publication Critical patent/FR2450108A1/fr
Application granted granted Critical
Publication of FR2450108B1 publication Critical patent/FR2450108B1/fr
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/225—Lactobacillus
    • C12R2001/245—Lactobacillus casei

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Microbiology (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Mycology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Virology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

L'INVENTION CONCERNE UN AGENT ANTITUMORAL. SELON L'INVENTION, IL CONTIENT LA SOUCHE DE LACTOBACILLUS CASEI YIT9018 COMME INGREDIENT EFFICACE. L'INVENTION S'APPLIQUE NOTAMMENT A LA LUTTE CONTRE LES TUMEURS ET LA LEUCEMIE.
FR8004213A 1979-02-27 1980-02-26 Agent antitumoral contenant la souche lactobacillus casei yit 9018 Expired FR2450108B1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2133979A JPS55113718A (en) 1979-02-27 1979-02-27 Antitumor agent

Publications (2)

Publication Number Publication Date
FR2450108A1 true FR2450108A1 (fr) 1980-09-26
FR2450108B1 FR2450108B1 (fr) 1988-10-28

Family

ID=12052351

Family Applications (1)

Application Number Title Priority Date Filing Date
FR8004213A Expired FR2450108B1 (fr) 1979-02-27 1980-02-26 Agent antitumoral contenant la souche lactobacillus casei yit 9018

Country Status (12)

Country Link
US (1) US4347240A (fr)
JP (1) JPS55113718A (fr)
BR (1) BR8001129A (fr)
CA (1) CA1124176A (fr)
CH (1) CH653556A5 (fr)
DE (1) DE3007412A1 (fr)
FR (1) FR2450108B1 (fr)
HK (1) HK23784A (fr)
IT (1) IT1129802B (fr)
MY (1) MY8500010A (fr)
NL (1) NL189999C (fr)
SG (1) SG38183G (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1991005851A1 (fr) * 1989-10-10 1991-05-02 Tartusky Gosudarstvenny Universitet Souche de bacterie de lactobacillus casei subsp casei 37 de production d'une preparation biologique bacterienne

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3125797A1 (de) * 1981-06-30 1983-01-13 Rudolf Dr. Schuler Diaetetisches mittel
US5965414A (en) * 1985-11-04 1999-10-12 Microlife Technics, Inc. Process for producing yeast and mold inhibiting products with lactobacillus
JPH0696538B2 (ja) * 1985-12-19 1994-11-30 株式会社アドバンス 抗発癌剤
JPH0755908B2 (ja) * 1992-11-24 1995-06-14 財団法人京都パストゥール研究所 免疫機能助長剤
US5840318A (en) * 1993-05-11 1998-11-24 Immunom Technologies, Inc. Methods and compositions for modulating immune systems of animals
WO1994026114A1 (fr) * 1993-05-11 1994-11-24 Immunom Technologies, Inc. Procede de stimulation et de modulation du systeme immunitaire d'animaux a l'aide de compositions microbiennes
US7189834B2 (en) * 1993-05-11 2007-03-13 Marshall William E Oligoribonucleotides alert the immune system of animals to the imminence of microbial infection
US6180100B1 (en) * 1994-09-30 2001-01-30 Urex Biotech., Inc. Lactobacillus compositions and methods for treating urinary tract infections
AUPN907296A0 (en) * 1996-04-02 1996-04-26 Commonwealth Scientific And Industrial Research Organisation Biocontrol agents for use in treatment of opportunistic infections
US6319692B1 (en) 1996-06-26 2001-11-20 Kabushiki Kaisha Yakult Honsha Methods for transferring gene into chromosome
ES2360341T3 (es) * 1997-02-11 2011-06-03 Enterprise Ireland (Trading As Bioresearch Ireland) Cepas probióticas de lactobacillus salivarius y agentes antimicrobianos obtenidos a partir de las mismas.
AU749001B2 (en) * 1997-04-18 2002-06-13 Ganeden Biotech, Inc. Topical use of probiotic bacillus spores to prevent or control microbial infections
US6645506B1 (en) * 1997-04-18 2003-11-11 Ganeden Biotech, Inc. Topical compositions containing extracellular products of Pseudomonas lindbergii and Emu oil
ID29150A (id) * 1999-01-15 2001-08-02 Entpr Ireland Cs Penggunaan lactobacillus salivarius
PE20030283A1 (es) * 2001-07-26 2003-05-01 Alimentary Health Ltd Cepas de lactobacillus casei
ES2425221T3 (es) * 2003-05-30 2013-10-14 Amylin Pharmaceuticals, Llc Nuevos métodos y composiciones para suministro por vía transmucosa potenciado de péptidos y proteínas
CN1842588B (zh) * 2003-07-30 2010-09-29 Bhph有限公司 新乳酸菌、活体活化型乳酸菌制剂以及活体传染病的预防剂与治疗剂
US20050112097A1 (en) * 2003-11-26 2005-05-26 Hinton Golden S. Method for the treatment of cancer
MX2007009659A (es) * 2005-02-11 2008-01-16 Technologie Biolactis Inc Uso de lactobacillus kefiranofaciens en la forma de un probiotico y un simbiotico.
US8404823B2 (en) * 2006-10-27 2013-03-26 Kabushiki Kaisha Yakult Honsha Cytokine production regulator gene and use thereof
CN101626773B (zh) * 2006-11-02 2013-04-17 奥力有限公司 一种生体治愈促进剂
KR20100008831A (ko) * 2008-07-17 2010-01-27 주식회사 쎌바이오텍 락토바실러스 카제이 배양물을 유효성분으로 함유하는항암용 조성물
RU2546251C2 (ru) 2009-11-11 2015-04-10 Алиментари Хелс Лимитед Пробиотический штамм бифидобактерий
JP5600179B2 (ja) 2009-11-11 2014-10-01 アリメンタリー、ヘルス、リミテッド ビフィズス菌株
US11590179B2 (en) 2017-02-28 2023-02-28 Precisionbiotics Group Limited Bifidobacterium longum able to beneficially modulate immune response to respiratory virus infection
CA3092728A1 (fr) 2017-03-23 2018-09-27 Universiteit Antwerpen Nouvelle souche de lactobacillus casei probiotique et ses utilisations
EP4117697A1 (fr) 2020-03-13 2023-01-18 PrecisionBiotics Group Limited Bifidobacterium longum

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1514949A (fr) * 1965-06-01 1968-03-01 Texim Entpr Economique D Etat Procédé de fabrication d'une nouvelle substance à partir de culture de microorganisme du genre lactobacillus
FR8144M (fr) * 1967-08-30 1970-08-17
FR2244464A1 (en) * 1973-06-26 1975-04-18 Serozym Laboratoires Yeast, lacto- and colibacillus based compsns - used to modify intestinal flora, treat colitis and digestive disorders, etc.

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1514949A (fr) * 1965-06-01 1968-03-01 Texim Entpr Economique D Etat Procédé de fabrication d'une nouvelle substance à partir de culture de microorganisme du genre lactobacillus
FR8144M (fr) * 1967-08-30 1970-08-17
FR2244464A1 (en) * 1973-06-26 1975-04-18 Serozym Laboratoires Yeast, lacto- and colibacillus based compsns - used to modify intestinal flora, treat colitis and digestive disorders, etc.

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
CA1972 *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1991005851A1 (fr) * 1989-10-10 1991-05-02 Tartusky Gosudarstvenny Universitet Souche de bacterie de lactobacillus casei subsp casei 37 de production d'une preparation biologique bacterienne

Also Published As

Publication number Publication date
IT1129802B (it) 1986-06-11
IT8067302A0 (it) 1980-02-27
DE3007412A1 (de) 1980-11-06
SG38183G (en) 1984-07-20
FR2450108B1 (fr) 1988-10-28
NL8001045A (nl) 1980-08-29
JPS6234727B2 (fr) 1987-07-28
NL189999C (nl) 1993-10-01
BR8001129A (pt) 1980-11-04
JPS55113718A (en) 1980-09-02
MY8500010A (en) 1985-12-31
CH653556A5 (de) 1986-01-15
NL189999B (nl) 1993-05-03
US4347240A (en) 1982-08-31
HK23784A (en) 1984-03-23
CA1124176A (fr) 1982-05-25

Similar Documents

Publication Publication Date Title
AU2613995A (en) Lactobacillus strains of human origin, their compositions and uses thereof
AU540410B2 (en) Compositions and treatment utilizing anionic surfactants
FR2450108B1 (fr) Agent antitumoral contenant la souche lactobacillus casei yit 9018
AU2332188A (en) Compounds having antiprogestational and anti-estrogenic activities for the treatment of hormone-dependent tumors
DE69534599D1 (en) Intrazellulare expression von carboxypeptidase g2 in enzyme-prodrug-therapie
AU7707687A (en) Article of wearing apparel suitable for controlling body perspiration
ES8606289A1 (es) Un procedimiento para la preparacion de piridazinaminas.
AU7650294A (en) Aminocyclohexylesters and uses thereof
MY104685A (en) Substituted thiazoles and their use as fungicides.
EP0165726A3 (fr) Agent pour améliorer la microflore intestinale
AU4783693A (en) Menstrual shorts having improved fastening system
DE3586697D1 (en) Aktive thymopentin-analoga.
BG101893A (en) Nodulosporic acid derivatives
GR3002377T3 (en) Ifosfamide-mesna-lyophilized composition and process to prepare it
MY100936A (en) Pesticidal compositions and process for preparation thereof
MY128260A (en) Cyclopentane-and-pentene-b-amino acids
AU553269B2 (en) 2,3-diaryl-5-halo thiophenes
AU5580980A (en) 24,24-difluoro-25-hydroxy vitamin d3
AU3800685A (en) Indolophenanthridines
CA2293808A1 (fr) Diagnostic et traitement des affections liees a la surcharge en fer et des affections ferriprives, procedes et compositions appropries
AU2885992A (en) Strains of the trichoderma fungus, fungicide derived therefrom and process for using the same
AU5852580A (en) 3,4,5-trihydroxypiperidine compounds
EP0183538A3 (fr) 2,2'-Isopropylidène bis (tétrahydrofuranne) et procédé pour sa préparation
IE791212L (en) 2- azaergolines and 2 - aza -8 (or9)- ergolines
ES512583A0 (es) "procedimiento para la mejora de la amplificacion y de la expresion de vectores hibridos".